The SALL4 gene signature obtained from either our knockdown experiments or from data mining on primary lung cancer patients was compared to the drug signatures through the cMap site (http://www.broadinstitute.org/cmap/) with over thousands of expression profiling results upon drug treatments. Here, SALL4 is linked to lung carcinoma.